This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lieu, T. A.
Right arrow Articles by Shay, G. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lieu, T. A.
Right arrow Articles by Shay, G. F.
Related Collections
Right arrow Premature & Newborn
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

PEDIATRICS Vol. 103 No. 6 June 1999, p. e72

ELECTRONIC ARTICLE:
The Cost of Medical Care for Patients With Cystic Fibrosis in a Health Maintenance Organization

Received Jul 30, 1998; accepted Jan 12, 1999.

Tracy A. Lieu*, G. Thomas Ray*, Gail FarmerDagger , and Gregory F. ShayDagger

From the * Division of Research and Dagger  Department of Pediatrics, the Permanente Medical Group, Oakland, California.

Background.  Cystic fibrosis (CF) is the most common life-shortening genetic disorder among white individuals worldwide. Previous estimates of the costs of medical care have been based on expert opinion rather than observed costs. Accurate cost estimates are needed to enable evaluation of the cost-effectiveness of new interventions and prenatal genetic screening recommendations.

Objective.  To evaluate the cost of medical care for patients (N = 136) served by a health maintenance organization with a CF center.

Methods.  Retrospective analysis of data from computerized cost databases and the Cystic Fibrosis Foundation annual survey. Severity of disease was classified based on the percent predicted forced expiratory volume at 1 second.

Results.  The annual cost of medical care in 1996 averaged $13 300 and ranged from $6200 among patients with mild disease to $43 300 among patients with severe disease. Of total costs, 47% were from hospitalization, 18% were from DNase (Pulmozyme), 12% were from clinic visits, and 10% were from outpatient antibiotics. When the observed costs were used to estimate the costs of medical care for the entire population of CF patients in the United States, these costs were estimated to be $314 million per year in 1996 dollars.

Conclusions.  We conclude that the cost of medical care for CF varies greatly with severity but is substantial even among patients with mild disease. These findings underscore the need for strategies to ensure good health insurance coverage and high quality care for all individuals with this condition.  Key words:  cystic fibrosis, chronic conditions, cost, health services, managed care.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 ThoraxHome page
S. C Bell and P. J Robinson
Exacerbations in cystic fibrosis: 2 {middle dot} Prevention
Thorax, August 1, 2007; 62(8): 723 - 732.
[Abstract] [Full Text] [PDF]

Home page
 ThoraxHome page
J K Block, K L Vandemheen, E Tullis, D Fergusson, S Doucette, D Haase, Y Berthiaume, N Brown, P Wilcox, P Bye, et al.
Predictors of pulmonary exacerbations in patients with cystic fibrosis infected with multi-resistant bacteria
Thorax, November 1, 2006; 61(11): 969 - 974.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
B. C. Marshall
Pulmonary Exacerbations in Cystic Fibrosis: It's Time to Be Explicit!
Am. J. Respir. Crit. Care Med., April 1, 2004; 169(7): 781 - 782.
[Full Text] [PDF]